TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Redo Biosolutions AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
79,549
|
99,435
|
87,811 |
| Financial expenses |
172
|
1
|
5 |
| Earnings before taxes |
1,762
|
17,435
|
17,414 |
| EBITDA |
3,813
|
20,191
|
19,439 |
| Total assets |
159,469
|
73,149
|
55,689 |
| Current assets |
109,516
|
53,268
|
33,319 |
| Current liabilities |
88,672
|
26,234
|
23,615 |
| Equity capital |
69,760
|
45,955
|
32,075 |
| - share capital |
65
|
67
|
67 |
| Employees (average) |
5
|
4
|
3 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
43.7%
|
62.8%
|
57.6% |
| Turnover per employee |
15,910
|
24,859
|
29,270 |
| Profit as a percentage of turnover |
2.2%
|
17.5%
|
19.8% |
| Return on assets (ROA) |
1.2%
|
23.8%
|
31.3% |
| Current ratio |
123.5%
|
203.0%
|
141.1% |
| Return on equity (ROE) |
2.5%
|
37.9%
|
54.3% |
| Change turnover |
-16,597
|
11,171
|
46,497 |
| Change turnover % |
-17%
|
13%
|
113% |
| Chg. No. of employees |
1
|
1
|
3 |
| Chg. No. of employees % |
25%
|
33% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.